Baxter Reports Q1 2026 Earnings with Mixed Financial Results
Baxter (BAX) reported Q1 2026 earnings with revenue of $2.7 billion, up 3% on a reported basis but down 1% organically. Adjusted earnings per share fell 35% to $0.36, driven by cost timing shifts, tariffs, and higher manufacturing costs. Free cash flow improved significantly to $76 million from negative $221 million in the prior year.
Topics: Earnings Financial Performance Margin Profit Revenue Segment Performance